Materials and Methods
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- A review on spinal cord stimulation.J Neurosurg Sci. 2012; 56: 287-298
- Spinal cord stimulation: an update.Neurotherapeutics. 2008; 5: 86-99https://doi.org/10.1016/j.nurt.2007.10.066
- Novel 10-kHz high-frequency therapy (HF10 therapy) is superior to traditional low-frequency spinal cord stimulation for the treatment of chronic back and leg pain: The SENZA-RCT randomized controlled trial.Anesthesiology. 2015; 123: 851-860https://doi.org/10.1097/ALN.0000000000000774
- The efficacy of high-density spinal cord stimulation among trial, implant, and conversion patients: a retrospective case series.Neuromodulation. 2017; 20: 654-660https://doi.org/10.1111/ner.12612
- Spinal cord stimulation (SCS) with anatomically guided (3D) neural targeting shows superior chronic axial low back pain relief compared to traditional SCS-Lumina study.Pain Med. 2017; 18: 1534-1548https://doi.org/10.1093/pm/pnw286
- Neuromodulation using ultra low frequency current waveform reversibly blocks axonal conduction and chronic pain.Sci Transl Med. 2021; 13eabg9890https://doi.org/10.1126/scitranslmed.abg9890
- Mimicking the brain: evaluation of St Jude Medical’s Prodigy Chronic Pain System with Burst Technology.Expert Rev Med Devices. 2015; 12: 143-150https://doi.org/10.1586/17434440.2015.985652
- All bursts are equal, but some are more equal (to burst firing): burstDR stimulation versus Boston burst stimulation.Expert Rev Med Devices. 2020; 17: 289-295https://doi.org/10.1080/17434440.2020.1736560
- Success using neuromodulation with BURST (SUNBURST) study: results from a prospective, randomized controlled trial using a novel burst waveform.Neuromodulation. 2018; 21: 56-66https://doi.org/10.1111/ner.12698
- An integrated quantitative index for measuring chronic multisite pain: the multiple areas of pain (MAP) study.Pain Med. 2018; 19: 1425-1435https://doi.org/10.1093/pm/pnx325
- Prevalence of musculoskeletal symptoms in single and multiple body regions and effects of perceived risk of injury among manual handling workers.Spine (Phila Pa 1976). 2002; 27: 2166-2172https://doi.org/10.1097/00007632-200210010-00017
- Simple patterns behind complex spatial pain reporting? Assessing a classification of multisite pain reporting in the general population.Pain. 2007; 133: 174-182https://doi.org/10.1016/j.pain.2007.04.022
- Pain at multiple body sites and health-related quality of life in older adults: results from the North Staffordshire Osteoarthritis Project.Rheumatol (Oxf Engl). 2014; 53: 2071-2079https://doi.org/10.1093/rheumatology/keu240
- Number of pain sites is associated with demographic, lifestyle, and health-related factors in the general population.Eur J Pain. 2008; 12: 742-748https://doi.org/10.1016/j.ejpain.2007.11.005
- The prevalence rate and the role of the spatial extent of pain in nonspecific chronic back pain--a population-based study in the south-west of Germany.Pain Med. 2014; 15: 1200-1210https://doi.org/10.1111/pme.12286
- Chronic musculoskeletal pain rarely presents in a single body site: results from a UK population study.Rheumatol (Oxf Engl). 2007; 46: 1168-1170https://doi.org/10.1093/rheumatology/kem118
- Prospective analysis utilizing intraoperative neuromonitoring for the evaluation of inter-burst frequencies.J Pain Res. 2021; 14: 703-710https://doi.org/10.2147/JPR.S298797
- Nonawake vs awake placement of spinal cord stimulators: a prospective, multicenter study comparing safety and efficacy.Neurosurgery. 2019; 84: 198-205https://doi.org/10.1093/neuros/nyy062
- Awake vs. asleep placement of spinal cord stimulators: a cohort analysis of complications associated with placement.Neuromodulation. 2011; 14 ([discussion: 134–135]): 130-134
- An observational case series of spinal cord stimulation waveforms visualized on intraoperative neuromonitoring.Neuromodulation. 2019; 22: 219-228https://doi.org/10.1111/ner.12781
- Mechanism of action in burst spinal cord stimulation: review and recent advances.Pain Med. 2019; 20: S13-S22https://doi.org/10.1093/pm/pnz073
- The Neurostimulation Appropriateness Consensus Committee (NACC) safety guidelines for the reduction of severe neurological injury.Neuromodulation. 2017; 20: 15-30https://doi.org/10.1111/ner.12564
- Neuromonitoring protocol for spinal cord stimulator cases with case descriptions.Int J Acad Med. 2016; 2: 132-144
- Spinal cord stimulation with interleaved pulses: a randomized, controlled trial.Neuromodulation. 2007; 10: 349-357https://doi.org/10.1111/j.1525-1403.2007.00123.x
- Novel intermittent dosing burst paradigm in spinal cord stimulation.Neuromodulation. 2021; 24: 566-573https://doi.org/10.1111/ner.13143
Publication stageIn Press Corrected Proof
Source(s) of financial support: This study was funded by Abbott.
Conflict of Interest: Steven M. Falowski is a consultant for Abbott, Medtronic, Saluda, Vertiflex, Boston Scientific, Vertos, Surgentec, Cornerloc, Mainstay, and Relievant and conducts research for Abbott, Medtronic, Saluda, and Nuvectra. He is a minor equity holder for Aurora Spina, Thermaquil, SPR Therapeutics, Saluda, Cornerloc, Painteq, Stimgenics, AGR, Neural Integrative Solutions, Spinethera, and Celeri. Alexander M. Benison and Ameya C. Nanivadekar are employees with Abbott.